Skip to content
  • FAQ
  • Contact

FIP Capetown 2024

82ND FIP WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

  • Register
    Registration fees Registration guidelines Registration forms
  • Abstracts
    Call for abstracts Guidelines for poster presenters
  • Programme
    Programme per day (in SAST) Programme overview (in SAST) General events Social events Programme theme Continuing Professional Development (CPD) points Young Scientist Award
  • Info
    Latest information Cape Town Venue Sightseeing Tours Professional Tours Important dates Travel advice Pharmacy in South Africa
  • Housing & Visa
    Accommodation Visa information for South Africa
  • Organisation
    FIP Congress partner Supporting (member) organisations and associations
  • Partners & exhibitors
    General information Confirmed partners & exhibitors Exhibitors floorplan
  • Media
    Banners and adverts Press registration Media Partners

RFMO-07 - Rapid fire session from selected oral abstracts

Roof Terrace room Monday 2 September 2024, 11:00-12:30

    (SEC) Health and medicines information

    • RFMO-0701 - Factors affecting Influenza-vaccine acceptance, hesitancy, and refusal in the 2023/2024 seasonal campaign
    • RFMO-0702 - Factors affecting COVID-19-vaccine hesitancy, acceptance and refusal in the 2023/2024 seasonal campaign
    • RFMO-0703 - Prices, Availability, and Affordability of Adult Medicines in 54 Low-Income and Middle-Income Countries: Evidence Based on a Secondary Analysis

    (SEC) Hospital pharmacy

    • RFMO-0704 - Enhancing clinical hospital pharmacy services in Wales: An independent review and recommendations
    • RFMO-0705 - Maximizing patient care and cost savings: The vital role of clinical pharmacists' interventions in a developing country
    • RFMO-0706 - Insights from Taipei Medical University Hospital
    • RFMO-0707 - Bi-directional texting for better outcomes: Enhancing patient safety and satisfaction beyond hospital walls
    • RFMO-0708 - Pharmacie-Rural. Validation of a medication related readmission risk tool

    Follow us

    fip © Copyright International Pharmaceutical Federation 2025
    • Privacy statement
    • Disclaimer
    • Scroll to top